Changes of hypothalamic and plasma vasopressin in rats with deoxycorticosterone-acetate induced salt appetite

Journal of Steroid Biochemistry and Molecular Biology

Volumn 70, Issue 1-3, 1999, Pages 47-57

  Saravia, Flavia E ^a,b   Grillo, Claudia A ^a,b   Ferrini, Mónica ^a   Roig, Paulina ^a   Lima, Analia E ^a   De Kloet, E Ronald ^d   De Nicola, Alejandro F ^a,b,c  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Argentina   (Argentina)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYCORTICOSTERONE ACETATE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRINKING; HYPERTENSION; HYPOTHALAMUS; MALE; NEUROHYPOPHYSIS; NONHUMAN; RAT; SALT INTAKE; SODIUM APPETITE;

ANIMALS; APPETITE; DESOXYCORTICOSTERONE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE, DIETARY; VASOPRESSINS;

EID: 0032858594     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00094-1     Document Type: Article

References (48)

1. Fregly M.J., Waters I.W. Effects of mineralocorticoids on spontaneous sodium chloride appetite in adrenalectomized rats. Physiol. Behav. 1:1966;65-74.
2. McEwen B.S., Lambdin L.T., Rainbow T.C., De Nicola A.F. Aldosterone effects on salt appetite in adrenalectomized rats. Neuroendocrinology. 43:1986;38-43.
3. Wolf G. Effect of deoxycorticosterone on sodium appetite of intact and adrenalectomized rats. Am. J. Physiol. 6:1965;1281-1285.
4. Gomez-Sanchez E.P. Central hypertensive effects of aldosterone. Front. Neuroendocrinol. 18:1997;440-463.
5. Lassman N.M., Mulrow P.J. Defficiency of deoxycorticosterone-binding protein in the hypothalamus of rats resistant to deoxycorticosterone-induced hypertension. Endocrinology. 94:1974;1541-1546.
6. Van den Berg D.T.W.M., De Kloet E.R., De Jong W. Central effects of mineralocorticoid antagonists Ru 28318 on blood pressure of DOCA-salt hypertensive rat. Am. J. Physiol. 267:1994;E927-E933.
7. Vallee S.M., Grillo C.A., Gonzalez S., Cosen-Binker L., de Kloet E.R., McEwen B.S., De Nicola A.F. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake. Neuroendocrinology. 61:1995;117-124.
8. Grillo C.A., Coirini H., McEwen B.S., De Nicola A.F. Changes of salt intake and of (Na,K)-ATPase activity in brain after high dose treatment with deoxycorticosterone. Brain Res. 499:1989;225-233.
9. Grillo C.A., Vallee S.M., Piroli G., Angulo J., McEwen B.S., De Nicola A.F. Effec of deoxycorticosterone acetate on β-subunit mRNA for (Na+K)-ATPase in brain regions determined by in situ hybridization. Cell. Mol. Neurobiol. 11:1991;347-356.
10. Grillo C.A., Saravia F.E., Ferrini M., Piroli G., Roig P., Garcia S., De Kloet E.R., De Nicola A.F. Increased expression of magnocellular vasopressin mRNA in rats with DOCA-induced salt appetite. Neuroendocrinology. 68:1998;105-115.
11. Reul J.M.H.M., De Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 117:1985;2505-2511.
12. Schulkin J., Ruger J. Relation between lateral hypothalamic damage and impairment of sodium appetite: evidence of subcortical mass action. Behav. Neural Biol. 30:1980;90-96.
13. Nitabach M.N., Schulkin J., Epstein A.N. The medial amygdala is part of a mineralocorticoid-sensitive circuit controlling NaCl intake in the rat. Behav. Brain Res. 35:1989;127-134.
14. Renaud L.P. CNS pathways mediating cardiovascular regulation of vasopressin. Clin. Exp. Pharmacol. Physiol. 23:1996;157-160.
15. Veltmar A., Culman J., Quadri F., Rascher W., Unger T. Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the intracerebroventricular angiotensin II-induced vasopressin release. J. Pharmacol. Exp. Ther. 263:1992;1253-1260.
16. Lenkei Z., Corvol P., Llorens-Cortes C. Comparative expression of vasopressin and angiotensin type-1 receptor mRNA in rat hypothalamic nuclei: a double in situ hybridization study. Mol. Brain Res. 34:1995;135-142.
17. Szczepanska-Sadowska E. Interaction of vasopressin and angiotensin II in central control of blood pressure and thirst. Reg. Peptides. 66:1996;65-71.
18. Landry M., Roche D., Calas A. Short-term effects of centrally administered galanin on the hyperosmotically stimulated expression of vasopressin in the rat hypothalamus. Neuroendocrinology. 61:1995;393-404.
19. Planas B., Kolb P.E., Raskind M.A., Miller M.A. Vasopressin and galanin mRNAs coexist in the nucleus of the horizontal diagonal band: novel site of vasopressin gene expression. J. Comp. Neurol. 361:1995;48-56.
20. Young Scott W. III. Corticotropin-releasing factor mRNA in the hypothalamus is affected differently by drinking saline and by dehydration. FEBS. 208:1986;158-162.
21. Hatton G.I. Function-related plasticity in hypothalamus. Ann. Rev. Neurosci. 20:1997;375-397.
22. Sawchenko P.E., Swanson L.W., Vale W.W. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc. Natl. Acad. Sci. USA. 81:1984;1883-1887.
23. Swanson L.W., Simmons D.M. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J. Comp. Neurol. 285:1989;413-435.
24. Crofton J.T., Share L., Wang B.C., Shade R.E. Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension. Hypertension. 2:1980;424-431.
25. Saito T., Yajima T., Watanabe T. Involvement of AVP in the development and maintenance of hypertension in rats. Yoshida S., Share L., Yagi K. Antidiurectic Hormone. 1981;215-221 University Park Press, Maryland.
26. Zicha J., Kunes J., Lebl M., Pohlova I., Slaninova J., Jelinek J. Antidiuretic and pressor action of vasopressin in age-dependent DOCA-salt hypertension. Am. J. Physiol. 256:1989;R138-R145.
27. Swords B.H., Wyss J.M., Berecek K.H. Central vasopressin receptors are upregulated by deoxycorticosterone acetate. Brain Res. 559:1991;10-16.
28. Ashen M.D., Hartman R.D., Barraclough C.A., Petersen S.L., Hamlyn J.M. Vasopressin gene transcripts in mineralocorticoid hypertension: an in situ study. J. Hypertension. 10:1992;1317-1326.
29. Morris M., Keller M., Sundberg D.K. Changes in paraventricular vasopressin and oxytocin during the development of spontaneous hypertension. Hypertension. 5:1983;476-481.
30. Gavras H., Gavras I. Salt-induced hypertension: the interactive role of vasopressin and of the sympathetic nervous system. J. Hypertension. 7:1989;601-606.
31. Ivanyi T., Dohanics J., Verbalis J.G. Effect of chronic hyponatremia on central and peripheral oxytocin and vasopressin secretion rats. Neuroendocrinology. 61:1995;412-420.
32. Buijs R.M., Swaab D.F., Dogterom J., van Leeuwen R.F. Intra and extrahypothalamic vasopressin and oxytocin pathways in the rat. Cell Tissue Res. 186:1978;422-433.
33. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1982;Academic Press, Sydney.
34. Kiss J.Z., Martos J., Palkovits M. Hypothalamic paraventricular nucleus: a quantitative analysis of cytoarchitectonic subdivision in the rat. J. Comp. Neurol. 313:1991;563-573.
35. Ferrini M., Lima A., De Nicola A.F. Estradiol abolishes down regulation of glucocorticoid receptors in brain. Life Sci. 57:1995;2403-2412.
36. Morris M., Aleves Rocha M.J., Sim L.J., Johnson A.K., Callahan M.F. Dissociation between vasopressin and oxytocin mRNA and peptide secretion after AV3V lesions. Am. J. Physiol. 36:1994;R1640-R1645.
37. Angulo J.A., Ledoux M., McEwen B.S. Genomic effects of cold and isolation stress on magnocellular vasopressin mRNA-containing cells in the hypothalamus of the rat. J. Neurochem. 56:1991;2033-2038.
38. Rabito S.F., Carretero O.A., Scicli A.G. Evidence against a role of vasopressin in the maintenance of high blood pressure in mineralocorticoid and renovascular hypertension. Hypertension. 3:1981;34-38.
39. Berecek K.H., Murray R.D., Gross F., Brody M.J. Vasopressin and vascular reactivity in the development of DOCA hypertension in rats with hereditary diabetes insipidus. Hypertension. 4:1982;3-12.
40. Morris M. Neurohypophyseal response to dehydration in the spontaneously hypertensive rat. Hypertension. 4:1982;161-166.
41. Brody M.J., Johnson A.K. Role of the anteroventral third ventricular region in fluid and electrolyte balance, arterial pressure regulation and hypertension. Front. Neuroendocrinol. 6:1980;249-292.
42. Dellmann H.D., Rodriguez E.M., Pena P., Siegmund I. Immunohistochemical investigation of the magnocellular peptidergic hypothalamo-neurohypophysial system of the rat chronically stimulated by long-term administration of hypertonic saline. Neuroendocrinology. 47:1988;335-342.
43. Ota K., Kimura T., Inoue M., Funyu T., Shoji M., Sato K., Ohta M., Yamamoto T., Abe K. Effects of V1 and V2-vasopressin (AVP) antagonist on the pressor. AVP and atrial natriuretic peptide responses to a hypertonic saline infusion in conscious anephric rats. Eur. J. Endocrinol. 133:1995;127-132.
44. Prakash N., Fehr S., Mohr E., Richter D. Dendritic localization of rat vasopressin mRNA: ultrastructural analysis and mapping of targeting elements. Eur. J. Neurosci. 9:1997;523-532.
45. Saigo A., Takano Y., Matsumoto T., Tran M., Nakayama Y., Saito R., Yamada K., Kamiya H. Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats. Neurosci. Lett. 159:1993;187-190.
46. Saavedra J.M., Castren E., Gutkind J.S., Nazarali A.J. Regulation of brain atrial natriuretic peptide and angiotensin receptors: quantitative autoradiographic studies. Int. J. Neurobiol. 31:1989;257-295.
47. Hwang B.H., Wu J.-Y., Wieczorek C.M., Harding J.W., Erickson J.B., Wamsley J.K. Different pharmacological anatomy in the paraventricular hypothalamic nucleus, supraoptic nucleus, and suprachiasmatic nucleus of rats: quantitative autoradiography on angiotesin II receptor binding sites. Am. J. Anat. 176:1986;243-247.
48. Samson W.K. Natriuretic peptides. Trends Endocrinol. Metab. 3:1992;86-90.